Content about Fungal diseases

November 15, 2013

The Food and Drug Administration has approved a new drug for fungal infections of the skin made by Valeant Pharmaceuticals International, the drug maker said Friday.

LAVAL, Quebec — The Food and Drug Administration has approved a new drug for fungal infections of the skin made by Valeant Pharmaceuticals International, the drug maker said Friday.

The company announced the FDA approval of Luzu (luliconazole) cream in the 1% strength for treatment of athlete's foot, jock itch and ringworm in adults.

October 10, 2013

A new strength of a drug for athlete's foot made by Merz Pharma Group has become available, the company said Thursday.

GREENSBORO, N.C. — A new strength of a drug for athlete's foot made by Merz Pharma Group has become available, the company said Thursday.

Merz, the U.S. affiliate of Germany-based Merz Pharma Group, announced the nationwide availability of Naftin (naftifine hydrochloride) gel in the 2% strength, a topical treatment for the foot fungus infection known medically as tinea pedis. The company called the new drug an improvement on the original 1% Naftin.

July 2, 2013

The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.

NEW YORK — The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.

According to reports, the FDA approved a gel formulation of Merz's Naftin (naftifine), used to treat athlete's foot, known medically as tinea pedis.

A cream version of the drug is already approved, and the latest approval was based on two clinical trials of more than 1,700 patients, according to reports.

 

June 26, 2013

The Food and Drug Administration has approved a drug made by Astellas Pharma for treating fungal infections in children.

NORTHBROOK, Ill. — The Food and Drug Administration has approved a drug made by Astellas Pharma for treating fungal infections in children.

January 31, 2013

Research has shown that 3-in-4 women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced, citing an independent survey commissioned for Monistat.

TREVOSE, Pa. — Research has shown that three in four women will experience candidiasis, more commonly known as a vaginal yeast infection, and 67% are embarrassed by it, Insight Pharmaceuticals announced Wednesday, citing an independent survey commissioned for Monistat.

July 27, 2012

Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

PITTSBURGH — Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

Mylan announced the launch of itraconazole capsules in the 100-mg strength. The drug is a generic version of Johnson & Johnson's Sporanox, which is used to treat fungal infections that begin in the lungs blatsomycosis, histoplasmosis and aspergillosis in patients who are intolerant of or refractory to amphotericin B therapy. The drug also is used to treat fungal infections in the toenails and fingernails in patients without compromised immune systems.

May 31, 2012

MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

EL SEGUNDO, Calif. — MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

The brand is expanding its U.S. distribution and can be found at such retailers as Walmart and Target in key U.S. Hispanic markets, such as Los Angeles, Houston, Dallas and Chicago, the company said.

May 23, 2012

The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

Perrigo announced the approval of butoconazole nitrate 2% vaginal cream, a generic version of KV Pharmaceutical's Gynazole-1, used to treat vulvovaginal candidiasis, an infection caused by Candida fungus. KV voluntarily discontinued selling the drug in January 2009 due to manufacturing problems.

March 21, 2011

Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.

The market for the drug is $23 million, according to IMS Health.

March 8, 2011

3M's skin and wound care division has launched an easy-to-apply cream that is designed to relieve skin discomforts caused by fungal infections.

ST. PAUL, Minn. — 3M's skin and wound care division has launched an easy-to-apply cream that is designed to relieve skin discomforts caused by fungal infections.

New Cavilon antifungal cream, which is available in 2-oz. and 5-oz. tubes, is enriched with water-repelling ingredients, including 2% miconazole nitrate, an active ingredient that has been clinically proven to treat tinea corporis (ringworm), tinea pedis (athlete’s foot) and tinea cruris (jock itch), 3M said. The product also is approved for use on fungal infections caused by Candida albicans.

August 19, 2010

An anti-inflammatory drug approved 60 years ago may help fight against a fungal infection of...

June 9, 2010

The Food and Drug Administration has approved Breckenridge Pharmaceutical’s generic version of a fungal infection...